Redeye: Infracom - Transformative times ahead
Redeye maintains its positive view on Infracom following the Q1 2023 report, in which sales came in slightly below our expectations despite, once again, substantial acquired growth. At the same time, the EBIT margin was stronger than expected. Overall, we make minor forecast adjustments while our valuation is intact.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/